ViAqua is a startup based in Israel, most recent round Series A, 5 tracked investors.
ViAqua is a company headquartered in Israel. Its most recent tracked round is Series A. Brouky records 5 investors associated with the company.
ViAqua develops an oral delivery platform using RNA interference technology to improve disease resistance in aquaculture, specifically targeting viral diseases such as the White Spot Shrimp Virus through feed integration.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.